Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | NR2E3 | Q9Y5X4 | 1/20 | 0.31 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19999694 | 0.89 | MEN1 (0.37) | MEN1CYP2C19KMT2AALDH1A1TSHR | |
| SCHEMBL21074236 | 0.89 | MEN1 (0.37) | MEN1CYP2C19KMT2AALDH1A1TSHR | |
| SCHEMBL20988683 | 0.88 | MEN1 (0.30) | MEN1CYP2C19KMT2A | |
| SCHEMBL20349238 | 0.85 | MEN1 (0.32) | MEN1CYP2C19KMT2AALDH1A1TSHR | |
| SCHEMBL16716690 | 0.85 | MEN1 (0.32) | MEN1CYP2C19KMT2AALDH1A1TSHR | |
| SCHEMBL21074288 | 0.85 | MEN1 (0.32) | MEN1CYP2C19KMT2AALDH1A1TSHR | |
| SCHEMBL19999702 | 0.84 | MEN1 (0.33) | MEN1CYP2C19KMT2AALDH1A1TSHR | |
| SCHEMBL21074253 | 0.84 | MEN1 (0.33) | MEN1CYP2C19KMT2AALDH1A1TSHR | |
| SCHEMBL20349236 | 0.84 | MEN1 (0.33) | MEN1CYP2C19KMT2AALDH1A1TSHR | |
| SCHEMBL16716134 | 0.83 | MEN1 (0.34) | MEN1CYP2C19KMT2AALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192739-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-06-22 | — | — | US | disclosed |
| US-20200168818-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192739-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, ODC1 | MEN1 2512/4885CYP2C19 66/4885KMT2A 3416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.